Tag: drug discovery
INmune Bio taps Dirac-3S quantum machine to find new XPro uses
Quantum optimization, AI and conventional analytics will be applied under a collaboration announced by INmune Bio and Quantum Computing Inc.,…
Drylab raises $3M to let AI agents run experiments unattended
A $3M seed round has been raised by Drylab AI, led by Vertex Ventures Southeast Asia and India, with patent…
Arrowhead’s RNA drug cuts Alzheimer’s tau by 73% in early trial
Arrowhead reported interim Phase 1/2a data showing its injectable RNA therapy crossed the blood-brain barrier and cut cerebrospinal tau by…
Polyphron collects $20M to test drugs on lab-grown human tissue
Polyphron has raised $20 million in seed funding to grow living human tissue in an automated lab and simulate how…
Google and US government back $1.8B cell-modeling push
A Zuckerberg-founded nonprofit is assembling $1.8B for open biological AI data, backed by $300M from three tech partners and $500M…
Isomorphic Labs weighs a $40B price tag before its first trial
Alphabet's AI drug discovery spinout is back in the market less than five months after a $2.1 billion round.
Cradle signs a drug discovery deal with Hansa Biopharma
The Swedish drugmaker picked an AI protein-design platform over rivals to engineer its next autoimmune therapies.
Microsoft builds a world model to map biology before the lab
Microsoft Research's Quine links biology models, lab tools and published literature into one loop that already surfaced tumor-shifting compounds.